Tomsicek Michael John is a director of Milestone Pharmaceuticals Inc.
Person profile
Roles
Milestone Pharmaceuticals
Director
Acrivon Therapeutics
Director
Address
Bedford, Massachusetts
Employees
SEC CIK
Latest filings (excl ownership)
No filings
Latest ownership filings
4
Milestone Pharmaceuticals Inc.
9 Jun 23
4
Acrivon Therapeutics, Inc.
16 Nov 22
3
Acrivon Therapeutics, Inc.
9 Nov 22
4
Milestone Pharmaceuticals Inc.
21 Oct 22
4
Milestone Pharmaceuticals Inc.
11 Aug 22
4
CRISPR Therapeutics AG
10 Aug 21
4
Milestone Pharmaceuticals Inc.
29 Jul 21
4
CRISPR Therapeutics AG
12 Mar 21
4
CRISPR Therapeutics AG
6 Oct 20
4
CRISPR Therapeutics AG
3 Sep 20
Recent insider trades
Date | Company | Security | Transaction | Code | Indirect | 10b5-1 | $Price | #Shares | $Value | #Remaining |
---|---|---|---|---|---|---|---|---|---|---|
7 Jun 23 | MIST Milestone Pharmaceuticals | Stock Option Common Shares | Grant | Acquire A | No | No | 3.86 | 30,000 | 115.80 k | 30,000 |
14 Nov 22 | ACRV Acrivon Therapeutics | Stock Option Common Stock | Grant | Acquire A | No | No | 12.5 | 35,235 | 440.44 k | 35,235 |